Japanese platform for freelancers Zehitomo has secured $7.6 million in a Series B round led by DG Daiwa Ventures. In a separate development, women-focused health firm Naari has completed the acquisition of a portfolio of 10 Abbreviated New Drug Applications (ANDAs) from India-based Intas Pharmaceuticals, the company announced on Thursday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
